Regarding the worldwide situation about the COVID-19, we are sorry to announce that the conference “Cell-penetrating peptides: Next generation delivery systems” will be postponed.
The new dates for the conference will be
from Monday 5th to Wednesday 7th October 2020.
Monday April 27th
| 14:00 – 14:30 | Opening |
| 14:30 – 15:15 | Sarah Jones (UK)
“Spermatozoa and Schmidtea mediterranea as alternative models for the evaluation of CPPs and bioportides: Progress towards a non-hormonal male contraceptive and generation of a novel CPP.” |
| 15:15 – 15:40 | Christopher Aisenbrey (France)
“The LAH4 system for DNA delivery: The metamorphosis of a model peptide to a medical tool” |
| 15:40 – 16:10 | Coffee break |
| 16:10 – 16:35 | Hellen O McCarthy (Northern Ireland)
“Therapeutic Nucleic Acid Vaccinations: RALA peptide-mediated gene delivery via dissolving microneedles” |
| 16:35– 18:00 | 5 short talks (10 min + 2 questions) |
| 18:15 | Poster session 1 |
| 19:00 | Welcome cocktail |
Thuesday April 28th
| 9:30 – 10:15 | Pu Chen (Canada) (to be announced) |
| 10:15 – 10:55 | Ines Neundorf (Germany)
“Towards the design and biological activity of cell-permeable peptide-drug conjugates” |
| 10:55 – 11:25 | Coffee break |
| 11:25 – 12:10 | 3 short talks (10 min + 2 questions) |
| 12:10-14:30 | Lunch |
| 14:30 – 15:15 | Meritxell Teixido (Spain)
“Blood-Brain Barrier Shuttle Peptides, From Discovery to Applications” |
| 15:15 – 15:40 | Diana Costa (Portugal)
“Exploring the potential of peptide-plasmid DNA vectors for gene delivery in cancer therapy” |
| 15:40 – 17:00 | Coffee break + Poster session 2 |
| 17:00 – 18:00 | 4 short talks (10 min + 2 questions) |
Wednesday April 29th
| 9:30 – 10:15 | Henry David Herce (USA)
“Cell-Penetrating Peptides: From molecular mechanisms to therapeutic applications” |
| 10:15 – 10:40 | Astrid Walrant (France)
“Contributions of PIP2 to Penetratin internalization biophysical and affinity photocrosslinking approaches” |
| 10:40 – 11:10 | Coffee break |
| 11:10 – 11:40 | 2 short talks (10 min + 2 questions) |
| 11:40 – 12:05 | Kaido Kurrikoff (Estonia)
“Delivery of Therapeutic Nucleic Acid with CPPs – Development Towards Mammalian Models and Applications in Biotechnology” |
| 12:05 – 12:15 | Closing remarks |
